Gujarat Themis Biosyn Ltd.

BSE: GUJTHEM506879ISIN INE942C01045

Healthcare
Pharmaceuticals
BSE Healthcare

BSE listing

Share price

₹427.65+6.60 (+1.57%)

as of 18 Sep 2026

52W high: ₹479.45
52W low: ₹225.75
Off 52W high: -10.80%
1M return: +15.15%
3M return: +11.61%
6M return: +55.45%
1Y return: +11.75%
20D avg volume: 32,638
50 DMA: ₹384.80
200 DMA: ₹362.12

Key ratios Consolidated

Market cap: ₹5,566 Cr
Current price: ₹427.65
52W high / low: ₹479.45 / ₹225.75
Face value: ₹1.00
P/E: 0.00
P/B: —
EPS (TTM): ₹0.00
Book value / share: —
ROE: —
ROCE: —
Operating margin: —
Net margin: —
Debt / equity: —
Net debt: —
Interest cover: —
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: —

Financials

Metric	Q1 FY27
Income statement
	43.79
	0.13
	28.76
	7.73
	0.00
	4.72
	1.79
	3.97
	14.46
	15.17
	0.00
	15.17
	4.10
	11.07
	1.02
Key metrics
	20.93
	47.80%
	25.30%

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	43.79	44.23	43.37	42.35	35.87	37.74	—
	0.13	0.92	0.42	0.82	0.27	1.35	—
	28.76	30.82	26.91	24.40	24.03	23.00	—
	7.73	10.05	6.62	6.92	6.83	6.85	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	4.72	3.79	4.76	4.85	3.11	3.14	—
	1.79	1.91	0.96	0.04	0.04	0.07	—
	3.97	4.04	3.89	2.96	2.03	1.23	—
	14.46	17.52	11.48	11.16	12.21	12.33	—
	15.17	14.34	16.87	18.76	12.12	16.09	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	15.17	14.34	16.87	18.76	12.12	16.09	—
	4.10	3.45	4.41	4.50	3.06	4.09	—
	11.07	10.89	12.46	14.27	9.06	12.00	—
	1.02	1.00	1.14	1.31	0.83	1.10	—
Key metrics
	20.93	20.29	21.72	21.76	14.19	17.39	—
	47.80%	45.90%	50.10%	51.40%	39.60%	46.10%	—
	25.30%	24.60%	28.70%	33.70%	25.30%	31.80%	—
	—	3.80%	—	5.50%	—	5.80%	—
	22.10%	17.20%	—	—	—	—	—
	22.20%	-9.20%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	173.74	165.82	150.80	—
	2.29	2.43	2.43	—
	110.89	106.16	87.69	—
	31.32	30.43	25.78	—
	0.00	0.00	0.00	—
	18.12	16.51	12.64	—
	4.70	2.95	0.36	—
	14.86	12.92	5.37	—
	54.62	52.38	44.81	—
	65.14	62.09	65.54	—
	0.00	0.00	0.00	—
	65.14	62.09	65.54	—
	16.46	15.41	16.77	—
	48.69	46.68	48.77	—
	4.47	4.28	4.48	—
Key metrics
	84.70	77.96	71.27	—
	48.75%	47.00%	47.30%	—
	28.02%	28.20%	32.30%	—
	—	15.30%	23.50%	—
	—	10.00%	—	—
	—	-4.30%	—	—
	—	-123.75	-25.12	—
	—	1.04	1.87	—
	—	0.56	0.12	—
	—	156.74	18.20	—
	—	87.3	52.3	—
Balance sheet
	—	503.43	301.31	—
	—	88.78	51.97	—
	—	3.12	11.69	—
	—	60.92	31.24	—
	—	15.42	5.05	—
	—	6.02	2.14	—
	—	286.92	40.58	—
	—	36.65	14.65	—
	—	79.16	20.56	—
	—	159.86	29.89	—
	—	31.80	0.25	—
	—	128.06	29.64	—
	—	287.76	248.38	—
Cash flow
	—	48.78	91.03	—
	—	-172.28	-111.82	—
	—	114.93	26.01	—
	—	172.53	116.15	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 59.34%

Holder	Type	Holding	Previous	Change
Pharmaceutical Business Group [india] Ltd	Promoter Group	38.97%	—	—
Themis Medicare Limited	Promoter Group	17.50%	—	—
Quant Mutual Fund - Quant Small Cap Fund	Public	7.47%	—	—
Ayushmat Ltd	Public	2.78%	—	—
Sachin Dinesh Patel	Promoter	2.32%	—	—
Kotak Mahindra Life Insurance Company Ltd.	Public	2.17%	—	—
Bank Of India Small Cap Fund	Public	1.63%	—	—
Capri Global Capital Limited	Public	1.09%	—	—
Dinesh S Patel	Promoter Group	0.51%	—	—
Anay Rupen Choksi	Promoter	0.02%	—	—
Nysha Rupen Choksi	Promoter	0.02%	—	—
Reena S Patel	Promoter	0.00%	—	—
Jayshree D Patel	Promoter	0.00%	—	—
Dinesh Shantilal Patel	Promoter	0.00%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Kindly refer to the attachment.18 Sep 2026 · Corp. Action / Record Date
Please refer to the attachment.18 Sep 2026 · Company Update / Acquisition
Please refer to the Disclosure under Reg 30 of LODR.16 Sep 2026 · Company Update / Allotment of Equity Shares
Please refer to the Outcome of the Board meeting held on 10.09.202610 Sep 2026 · Board Meeting / Outcome of Board Meeting
Please refer to the attachment8 Sep 2026 · AGM/EGM / AGM
Gujarat Themis Biosyn Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/09/2026 ,inter alia, to consider and approve raising funds through ....7 Sep 2026 · Board Meeting / Board Meeting
Please refer to newspaper publication of 45th AGM notice .7 Sep 2026 · Company Update / Newspaper Publication
Please refer to attached BRSR for F.Y. 2025-264 Sep 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Please refer to our Annual Report for F.Y. 2025-264 Sep 2026 · Others / Reg. 34 (1) Annual Report
Please refer to the Notice of 45th Annual General Meeting scheduled on 30.09.20264 Sep 2026 · AGM/EGM / AGM
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pharmaceutical Business Group India Ltd & Others2 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Kindly refer to the outcome of the Board Meeting held on 01-09-20261 Sep 2026 · Board Meeting / Outcome of Board Meeting
Outcome of the Fund Raising Committee held on 28.08.2026 for allotment of equity shares through QIP28 Aug 2026 · Company Update / Allotment of Equity Shares
Outcome of Fund Raising Committee for QIP Issue Close28 Aug 2026 · Company Update / Qualified Institutional Placement
Gujarat Themis Biosyn Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/09/2026 ,inter alia, to consider and approve Please refer to the intimation ....27 Aug 2026 · Board Meeting / Board Meeting
Please refer to the attachment25 Aug 2026 · Others / Outcome without intimation
Please refer to our Announcement under Reg 30 (LODR) - Updates (Audited Financial Statements - F.Y. 2025-26)25 Aug 2026 · Company Update / General
Please refer to the attachment.23 Aug 2026 · Company Update / Amendments to Memorandum & Articles of Association
Please refer to the attachment.23 Aug 2026 · Company Update / Amendments to Memorandum & Articles of Association
Please refer to the attachment.22 Aug 2026 · AGM/EGM / Postal Ballot
Please refer to the attachment.22 Aug 2026 · AGM/EGM / Postal Ballot
Please refer to the attachment22 Aug 2026 · AGM/EGM / EGM
Please refer to the outcome / proceedings of EGM held on 22.08.202622 Aug 2026 · AGM/EGM / EGM
Earnings Call Transcript14 Aug 2026 · Company Update / Earnings Call Transcript
Please refer to our submission of Call Recordings of the investor/analyst Conference Call held on Monday, August 10, 2026 (IST).10 Aug 2026 · Company Update / Analyst / Investor Meet
Please refer to the copies of newspaper articles published for the un-audited financial results for the quarter ended 30.06.20269 Aug 2026 · Company Update / Newspaper Publication
Please refer to our investors presentation for the quarter ended 30.06.20267 Aug 2026 · Company Update / Investor Presentation
Please refer to the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June ,20267 Aug 2026 · Result / Financial Results
Please refer to the outcome of the Board meeting held on 07.08.20267 Aug 2026 · Board Meeting / Outcome of Board Meeting
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sachin D Patel5 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
Please refer to the concall invite to discuss the 1QFY27 Financial performance.4 Aug 2026 · Company Update / Analyst / Investor Meet
Please refer to the copies of Newspaper Publication of EGM Notice.2 Aug 2026 · Company Update / Newspaper Publication
Please refer to the attachment.31 Jul 2026 · AGM/EGM / EGM
Gujarat Themis Biosyn Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve the Un-Audited Financial ....31 Jul 2026 · Board Meeting / Board Meeting
Please refer to our copies of Newspaper Publication dated 24.07.2026 for Postal Ballot.24 Jul 2026 · Company Update / Newspaper Publication
Please refer to the Notice of Postal Ballot 22.07.202623 Jul 2026 · AGM/EGM / Postal Ballot
The Exchange has received the revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 ....21 Jul 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 21, 2026 for Pharmaceutical ....21 Jul 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 20, 2026 for Themis Medicare Ltd21 Jul 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 20, 2026 for Pharmaceutical ....21 Jul 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 0.6700	4 Sep 2025	5 Sep 2025	—
Bonus issue 1:2	9 Aug 2024	9 Aug 2024	—
Final Dividend - Rs. - 0.2500	15 Jul 2024	—	—

Board meetings

7 Aug 2026 Board Meeting - Financial Results